Effects of molindone: A Synthesis of Findings from 20 Studies
- Home
- Effects of molindone
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of molindone: A Synthesis of Findings from 20 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Main Research Findings
Several studies have shown that the effects of molindone depend on the dosage and duration of administration. A low dose (2.5 mg/kg) produced effects typical of DA receptor blockade, such as activation of synaptosomal tyrosine hydroxylase, increased DA metabolite levels, and unchanged DA levels. 6 A high dose (40 mg/kg) produced opposite effects, such as decreased tyrosine hydroxylase activity and metabolite concentrations, and elevated DA levels. 6 An intermediate dose of 10 mg/kg elicited intermediate effects. 6 These atypical effects of both higher doses were long-lasting (less than 72 hours). 6 Molindone at doses of 10 or 40 mg/kg, but not 2.5 mg/kg, selectively, irreversibly, and dose-dependently inhibited type A monoamine oxidase. 6 This inhibition appeared to be due to a metabolite, as the drug itself inhibited monoamine oxidase (reversibly) only at high concentrations (less than or equal to 10-4 M). 6 The previously unsuspected inhibition of monoamine oxidase by molindone provided a consistent mechanistic interpretation of the differential dose- and time-dependent effects of the drug on dopaminergic neuronal activity. 6 This mechanism may also serve to explain the reported efficacy of molindone in animal tests for antidepressant activity as well as its inability to produce increased DA receptor binding after chronic treatment. 6
Benefits and Risks
Benefit Summary
Molindone may be beneficial in treating impulsive aggression (IA) in patients with attention-deficit/hyperactivity disorder (ADHD). 17 It may also have antidepressant effects due to its inhibition of monoamine oxidase. 6
Risk Summary
Molindone may have adverse effects on dopamine neuron activity at high doses. 6 Side effects such as weight gain and sedation have also been reported. 19
Comparison between Studies
Commonalities between Studies
Multiple studies have shown that molindone affects dopamine neuron activity. 6 8 7 However, its effects differ depending on the dosage and duration of administration. 6 Additionally, several studies have reported that molindone inhibits monoamine oxidase. 6 5
Differences between Studies
Various research methods have been used to evaluate the effects of molindone. For example, some studies have measured dopamine levels in the brains of rats, 6 while others have examined the behavior of pigeons, 2 or conducted studies on humans with mental illnesses. These studies have yielded different results regarding the effects and side effects of molindone.
Consistency and Contradictions in Results
The effects of molindone vary significantly depending on factors such as dosage, duration, and individual differences, making it difficult to fully understand its effects. In particular, at high doses, it may have adverse effects on dopamine neuron activity, while at low doses, it may act as a DA receptor blocker. 6 Further research is necessary to explain these contradictory results.
Points to Note Regarding Applications in Real Life
Because the effects of molindone vary significantly depending on factors such as dosage, duration, and individual differences, it is crucial to select the appropriate dosage and administration method. 6 Molindone may also cause side effects such as weight gain and sedation. 19 Therefore, it is essential to use it as directed by a physician.
Limitations of Current Research
Research on the effects of molindone is still insufficient, particularly in humans. Long-term safety and efficacy data are limited, and further research is needed on factors that may affect molindone's effects, such as age, gender, genotype, and co-administered medications.
Future Research Directions
To gain a deeper understanding of the effects of molindone, long-term studies on humans are required. It is essential to examine the effects of various dosages, administration methods, and co-administered medications. Identifying the genes and proteins that may influence the effects of molindone could lead to personalized medication.
Conclusion
The effects of molindone depend on the dosage and duration of administration. 6 At low doses, it may act as a DA receptor blocker and have beneficial effects in treating impulsive aggression (IA) in patients with attention-deficit/hyperactivity disorder (ADHD). 17 However, at high doses, it may have adverse effects on dopamine neuron activity. 6 Side effects such as weight gain and sedation have also been reported. 19 When considering the use of molindone, it is essential to carefully evaluate these risks and benefits.
Benefit Keywords
Risk Keywords
Article Type
Author: DhawareB S, BalsaraJ J, NandalN V, ChandorkarA G
Language : English
Author: PolingA, ClearyJ, BerensK, ThompsonT
Language : English
Author: PickerM J, ClearyJ P, BerensK, OlivetoA H, DykstraL A
Language : English
Author: McMillenB A, McDonaldC C
Language : English
Author: MellerE, FriedmanE
Language : English
Author: BunneyB S, RothR H, AghajanianG K
Language : English
Author: CarnovaleCarla, BattiniVera, SantoroClaudia, RiccioMaria Pia, CarucciSara, NobileMaria, FormisanoPietro, BravaccioCarmela, ZuddasAlessandro, ClementiEmilio, PozziMarco, PisanoSimone
Language : English
Author: Lopez-MorinigoJavier-David, LeuchtStefan, ArangoCelso
Language : English
Author: YeeCaitlin S, BahjiAnees, LolichMaria, VázquezGustavo H, BaldessariniRoss J
Language : English
Author: GawlikMaciej, SavicVladimir, JovanovicMilos, SkibińskiRobert
Language : English
Author: SchoretsanitisGeorgios, de LeonJose, EapChin B, KaneJohn M, PaulzenMichael
Language : English
Author: NageyeFatuma, CorteseSamuele
Language : English
Author: RobbAdelaide S, SchwabeStefan, Ceresoli-BorroniGianpiera, NasserAzmi, YuChungping, MarcusRonald, CandlerShawn A, FindlingRobert L
Language : English
Author: YuChungping, GopalakrishnanGopakumar
Language : English
Reproductive toxicology studies supporting the safety of molindone, a dopamine receptor antagonist.
Author: GopalakrishnanGopakumar, GanigerShivaputhrappa, WhiteTacey E K, YuChungping
Language : English
Author: TaylorJerome H, JakubovskiEwgeni, GabrielDaniel, BlochMichael H
Language : English
Author: KrauseMarc, ZhuYikang, HuhnMaximilian, Schneider-ThomaJohannes, BighelliIrene, ChaimaniAnna, LeuchtStefan
Language : English
Author: ZhuYikang, KrauseMarc, HuhnMaximilian, RothePhilipp, Schneider-ThomaJohannes, ChaimaniAnna, LiChunbo, DavisJohn M, LeuchtStefan
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.